Safety, efficacy, and biomarkers of nivolumab with vaccine in ipilimumab-refractory or -naive melanoma (Q37333645)

From Wikidata
Revision as of 14:01, 2 August 2024 by Emijrpbot (talk | contribs) (‎Changed label, description and/or aliases in es: BOT - Adding descriptions (1 languages): es)
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to navigation Jump to search
scientific article published on 21 October 2013
edit
Language Label Description Also known as
English
Safety, efficacy, and biomarkers of nivolumab with vaccine in ipilimumab-refractory or -naive melanoma
scientific article published on 21 October 2013

    Statements

    Safety, efficacy, and biomarkers of nivolumab with vaccine in ipilimumab-refractory or -naive melanoma (English)
    Jeffrey S Weber
    Ragini Reiney Kudchadkar
    Donna Gallenstein
    Christine E Horak
    H David Inzunza
    Alberto J Martinez
    Geoffrey Gibney
    Cabell Eysmans
    Amod A Sarnaik

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit